Clinical Trial Update: Study of Efficacy and Safety of Flumatinib Combined With Chemotherapy in Ph Positive ALL [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of flumatinib in combination with chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Flumatinib (flumatinib)

Snippet

Sponsor: Zhongda Hospital | Conditions: Acute Lymphocytic Leukemia, Adult B-Cell, BCR-ABL1 Fusion Protein Expression | Phase 3 | Status: UNKNOWN